Skip to main content
main-content
Top

10-11-2016 | Pembrolizumab | Article

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Reck M et al. N Engl J Med 2016; 375: 1823-1833. doi: 10.1056/NEJMoa1606774

Please log in to get access to this content

Related topics